Synthesis and characterization of nonsteroidal-linked M(CO) 3+(M = 99mTc, Re) compounds based on the androgen receptor targeting molecule flutamide

Bioconjugate Chemistry

Volumn 20, Issue 1, 2009, Pages 78-86

  He, Haiyang ^a   Morely, Jennifer E ^a   Silva Lopez, Elsa ^a   Bottenus, Brienne ^a   Montajano, Maribel ^a   Fugate, Glenn A ^a   Twamley, Brendan ^b   Benny, Paul D ^a  

^a WASHINGTON STATE UNIVERSITY   (United States)

^b UNIVERSITY OF IDAHO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DISEASES; LIGANDS; ORGANOMETALLICS; PARTICLE BEAMS; RADIOACTIVITY; RHENIUM COMPOUNDS; SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY; SYNTHESIS (CHEMICAL);

ANDROGEN RECEPTORS; IMAGING AGENT; IMIDAZOL; PROSTATE CANCERS; RADIOACTIVE IMAGING; RECEPTOR TARGETING; SYNTHESIS AND CHARACTERIZATIONS; TARGETING MOLECULES; TOMOGRAPHY IMAGING; TRIFLUOROMETHYL;

AMINO ACIDS;

2 (1H IMIDAZOL 1 YL ) N [4 NITRO 3 (TRIFLUOROMETHYL)PHENYL]ACETAMIDE; 2 (CYSTEINYL) N [4 NITRO 3 (TRIFLUOROMETHYL)PHENYL]ACETAMIDE; 2 AMINO 3 [1 [2 (4 NITRO 3 (TRIFLUOROMETHYL)PHENYLAMINO) 2 OXOETHYL] 1H IMIDAZOL 4 YL]PROPANOIC ACID; 2 BROMO N [4 NITRO 3 (TRIFLUOROMETHYL)PHENYL]ACETAMIDE; ANDROGEN RECEPTOR; ANTINEOPLASTIC AGENT; FLUTAMIDE; RADIOPHARMACEUTICAL AGENT; TECHNETIUM 99M; UNCLASSIFIED DRUG;

ARTICLE; CHELATION; COMPLEX FORMATION; DIAGNOSTIC IMAGING; DRUG CONJUGATION; DRUG SYNTHESIS; DRUG TARGETING; PROSTATE CANCER; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

EID: 61849131588     PISSN: 10431802     EISSN: None     Source Type: Journal    
DOI: 10.1021/bc8003183     Document Type: Article

References (43)

1. Jemal, A., Siegel, R., Ward, E., Murray, T., Xu, J. Q., and Thun, M. J. (2007) Cancer statistics, 2007. Ca-a Cancer Journal for Clinicians 57, 43-66.
2. http://www.cancer.gov/cancertopics/pdq/treatment/prostate/ patient.
3. http://www.prostate-cancer.com/.
4. Culig, Z. R., Klocker, H., Bartsch, G., Steiner, H., and Hobisch, A. (2003) Androgen receptors in prostate cancer. J. Urol. 170, 1363-1369.
5. DeMarzo, A. M., Nelson, W. G., Isaacs, W. B., and Epstein, J. I. (2003) Pathological and molecular aspects of prostate cancer. Lancet 361, 955-964.
6. Singh, S. M., Gauthier, S., and Labrie, F. (2000) Androgen receptor antagonists (antiandrogens): Structure-activity relationships. Curr. Med. Chem. 7, 211-247.
7. Gao, W. Q., Kearbey, J. D., Nair, V. A., Chung, K. W., Parlow, A. F., Miller, D. D., and Dalton, J. T. (2004) Comparison of the pharmacological effects of a novel selective androgen receptor modulator, the 5 alpha-reductase inhibitor finasteride, and the antiandrogen hydroxyflutamide in intact rats: New approach for benign prostate hyperplasia. Endocrinology 145, 5420-5428.
8. Urushibara, M., Ishioka, J., Hyochi, N., Kihara, K., Hara, S., Singh, P., Isaacs, J. T., and Kageyama, Y. (2007) Effects of steroidal and non-steroidal antiandrogens on wild-type and mutant androgen receptors. Prostate 67, 799-807.
9. Yin, D. H., He, Y. L., Perera, M. A., Hong, S. S., Marhefka, C., Stourman, N., Krikovsky, L., Miller, D. D., and Dalton, J. T. (2003) Key structural features of nonsteroidal ligands for binding and activation of the androgen receptor. Mol. Pharmacol. 63, 211-223.
10. Bohl, C. E., Chang, C., Mohler, M. L., Chen, J. Y., Miller, D. D., Swaan, P. W., and Dalton, J. T. (2004) A ligand-based approach to identify quantitative structure-activity relationships for the androgen receptor. J. Med. Chem. 47, 3765-3776.
11. Miller, D. D., He, Y. L., Marhefka, C. A., Rakov, I. M., Hong, S. S., Hwang, D. J., Mohler, M. L., Kirichenko, S. N., Mustafa, S. M., Nair, V. A., Patil, R., Chung, K. W., Veverka, K. A., Steiner, M. S., Barnette, K. G., Yin, D. H., Gao, W. Q., Kearbey, J. D., Xu, H. P., Kim, J., Chen, J. Y., Bohl, C., and Dalton, J. T. (2003) Novel selective androgen receptor modulators (S ARMs). Abstr. Pap. Am. Chem. Soc. 226, Ul-Ul.
12. Isaacs, J. T., and Isaacs, W. B. (2004) Androgen receptor outwits prostate cancer drugs. Nat. Med. 10, 26-27.
13. Parent, E. E., Dence, C. S., Jenks, C., Sharp, T. L., Welch, M. J., and Katzenellenbogen, J. A. (2007) Synthesis and biological evaluation of [F-18]bicalutamide, 4-[Br-76]bromobi-calutamide, and 4-[Br-76]bromo- thiobicalutamide as nonsteroidal androgens for prostate cancer imaging. J Med. Chem. 50, 1028-1040.
14. Payen, O., Top, S., Vessieres, A., Brule, E., Plamont, M. A., McGlinchey, M. J., Muller-Bunz, H., and Jaouen, G. (2008) Synthesis and structure-activity relationships of the first ferrocenyl-aryl-hydantoin derivatives of the nonsteroidal antiandrogen nilutamide. J. Med. Chem. 51, 1791-1799.
15. Nair, V. A., Mustafa, S. M., Mohler, M. L., Yang, J., Kirkovsky, L. I., Dalton, J. T., and Miller, D. D. (2005) Synthesis of irreversibly binding bicalutamide analogs for imaging studies. Tetrahedron Lett. 46, 4821-4823.
16. Nair, V. A., Mustafa, S. M., Mohler, M. L., Fisher, S. J., Dalton, J. T., and Miller, D. D. (2004) Synthesis of novel iodo derived bicalutamide analogs. Tetrahedron Lett. 45, 9475-9477.
17. Choe, Y. S., Lidstrom, P. J., Chi, D. Y., Bonasera, T. A., Welch, M. J., and Katzenellenbogen, J. A. (1995) Synthesis of ll-β-[F-18]fluoro-5- α-dihydrotestosterone and ll-β-[F-18]fluoro-19-nor-5-α- Dihydrotestosterone - preparation via halofluorination-reduction, receptor-binding, and tissue distribution. J. Med. Chem. 38, 816-825.
18. Jurisson, S. S., and Lydon, J. D. (1999) Potential technetium small molecule radiopharmaceuticals. Chem. Rev. 99, 2205-2218.
19. 99mTclabeled testosterone derivative as a potential agent for targeting androgen receptors. Bioorg. Med. Chem. Lett. 16, 5788-5792.
20. + under CO pressure in aqueous media: A single sample story. Angew. Chem.-Int. Ed. 39, 254.
21. 99mTc-carbonyls. Biopolymers 76, 324-333.
22. - in aqueous solution and its reaction with a bifunctional ligand. J. Am. Chem. Soc. 120, 7987-7988.
23. 99mTc. J. Am. Chem. Soc. 121, 6076-6077.
24. + (M = Re, Tc) directed towards radiopharmaceutical application. Coord. Chem. Rev. 192, 901-919.
25. +. J. Am. Chem. Soc. 123, 3135-3136.
26. 99mTc imaging agents. Structural characterization and solution behavior of complexes with thioetherbearing amino acids as tridentate ligands. Inorg. Chem. 44, 5437-5446.
27. 99mTc(I)-tricarbonyl complexes: A hint for the future functionalization of biomolecules. Bioconjugate Chem. 11, 345-351.
28. +. Chem. Eur. J. 9, 2053-2061.
29. Hope, H. (1994) X-ray crystallography - a fast, first-resort analytical tool. Prog, lnorg. Chem. 41, 41-119.
30. SAlNTPlus: v. 6.45a and v.7.23a, Data Reduction and Correction Program (2003/2004) Bruker AXS, Madison, WI.
31. SADABS: v.2.01, v. 2004/1 an empirical absorption correction program (2004) Bruker AXS Inc., Madison, WI.
32. SHELXTL: v. 6.14, Structure Determination Software Suite (2004) Sheldrick, G. M.,Bruker AXS Inc., Madison, WI.
33. 3-pyrazolyl conjugate of cyclo-(Arg-Gly-Asp-D-Tyr-Lys). Bioconjugate Chem. 18, 530-537.
34. Soderholm, A. A., Lehtovuori, P. T., and Nyronen, T. H. (2005) Three-dimensional structure-activity relationships of nonsteroidal ligands in complex with androgen receptor ligand-binding domain. J. Med. Chem. 48, 917-925.
35. Van Dort, M. E., and Jung, Y. W. (2001) Synthesis and structure-activity studies of side-chain derivatized arylhydantoins for investigation as androgen receptor radioligands. Bioorg. Med. Chem. Lett. 11, 1045-1047.
36. Jacobson, O., Bechor, Y., Icar, A., Novak, N., Birman, A., Marom, H., Fadeeva, L., Golan, E., Leibovitch, I., Gutman, M., Even-Sapir, E., Chisin, R., Gozin, M., and Mishani, E. (2005) Prostate cancer PET bioprobes: Synthesis of [F-18]-radiolabeled hydroxyflutamide derivatives. Bioorg. Med. Chem. 13, 6195-6205.
37. Van Dort, M. E., and Jung, Y. W. (2004) Synthesis and structure-activity investigation of iodinated arylhydantoins and arylthiohydantoins for development as androgen receptor radioligands. Bioorg. Med. Chem. Lett. 14, 5285-5288.
38. +. Helv. Chim. Acta 88, 447-460.
39. Narayanan, S., Vangapandu, S., and Jain, R. (2001) Regiospecific synthesis of 2,3-disubstituted-L-histidines and histamines. Bioorg. Med. Chem. Lett. 11, 1133-1136.
40. Kovalainen, J. T., Christiaans, J. A. M., Kotisaari, S., Laitinen, J. T., Mannisto, P. T., Tuomisto, L., and Gynther, J. (1999) Synthesis and in vitro pharmacology of a series of new chiral histamine H-3-receptor ligands: 2-(R and S)-amino-3-(lH-imidazol-4(5)-yl)propyl ether derivatives. J. Med. Chem. 42, 1193-1202.
41. +: a basic study. Dalton Trans. 1320-1328.
42. 2-. lnorg. Chim. Acta, in press.
43. +. Org. Biomol. Chem. 2, 2593-2603.